Morgan Stanley’s Universe Pharmaceuticals Inc UPC Stock Holding History

Morgan Stanley’s Portfolio UPC Stock Details UPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2	Closed	-$40	–	8218
2024 Q4	$40	Buy	+2	New	+$232	﹤0.01%	7701

Other funds holding UPC

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley's UPC Position: Q1 2025 in Review

Morgan Stanley sold out of Universe Pharmaceuticals Inc (UPC) in Q1 2025, closing a stake of 2 shares — an estimated $40 sold.

Morgan Stanley first reported a position in UPC in Q4 2024 and held it in 1 quarter. The position peaked at $40 in Q4 2024. 1 fund tracked by Wall St. Rank holds UPC as of Q1 2025.

Morgan Stanley reported no remaining Universe Pharmaceuticals Inc position as of Q1 2025 after selling out during the quarter.
Morgan Stanley sold 2 Universe Pharmaceuticals Inc shares in Q1 2025, an estimated $40.
Morgan Stanley first reported a position in Universe Pharmaceuticals Inc in Q4 2024 and held it in 1 quarter.
Morgan Stanley's Universe Pharmaceuticals Inc position peaked at $40 in Q4 2024.
1 fund tracked by Wall St. Rank held Universe Pharmaceuticals Inc as of Q1 2025.

Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.